NEJM at ESMO — Adjuvant Pembrolizumab Versus Observation in Muscle-Invasive Urothelial Carcinoma
The New England journal of medicine（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined